Position in MRNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$38,806,475
+$24,100,019 QoQ
Shares Held
763,907
+53.2% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lingotto Investment Management LLP holds $56,863,410 across 2 Biotechnology names. MRNA ranks #1 (68.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
763,907 | $38,806,475 | |
| 2 | RXRX |
Recursion Pharmaceuticals, Inc.
|
5,881,738 | $18,056,935 |
All Filings in MRNA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,806,475 | 763,907 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,706,456 | 498,693 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,637,043 | 373,095 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,293,691 | 373,095 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,577,243 | 373,095 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,513,290 | 373,095 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $24,933,938 | 373,095 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $41,336,281 | 348,095 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $32,297,803 | 303,095 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $23,181,297 | 233,095 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,747,382 | 133,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,171,042 | 133,095 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||